AMRS News and Press, Amyris Inc. From 03/16/23

2023-03-16 17:18:52 ET Amyris ( NASDAQ: AMRS ) has filed for a $1B mixed shelf offering. The filing does not necessarily indicate that a sale has begun or will occur in the future. The offering may include common stock, preferred stock, warrants, debt securities, and u...

2023-03-16 09:10:41 ET Esperion Therapeutics ESPR -58% in dustup with Daiichi Sankyo over milestone payments . LivePerson LPSN -38% on Q4 earnings release . Virgin Orbit VORB -37% on reports it's pausing operations as it seeks funding . First Republ...

2023-03-16 06:26:04 ET The following slide deck was published by Amyris, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Amyris, Inc. 2022 Q4 - Results - Earnings Call Presentation

2023-03-16 00:23:04 ET Amyris, Inc. (AMRS) Q4 2022 Earnings Conference Call March 15, 2023 16:30 ET Company Participants Han Kieftenbeld - Chief Financial Officer John Melo - President and Chief Executive Officer Eduardo Alvarez - Chief Operating Officer Co...

2023-03-15 18:27:00 ET Amyris stock is down ~8% in after-hours trading after the synthetic biotech company reported Q4 2022 financial results that missed on the bottom line. Though Q4 2022 revenue of $75.8M was a 17% year-over-year increase, it came in $28.3M below expect...

2023-03-15 16:15:14 ET Amyris press release ( NASDAQ: AMRS ): Q4 EPS of -$0.46 may not be comparable to consensus of -$0.03. Revenue of $75.8M (+17.0% Y/Y) misses by $28.3M . Fourth quarter Consumer revenue of $52.8 million increased 64% over the prior year and was...

AMYRIS, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS PR Newswire Fourth quarter Consumer revenue of $52.8 million increased 64% over the prior year and was another record quarter. Core revenue of $75.8 million grew 17% over the prior year ...

Summary Strategic transactions are a form of financing, and should be viewed as such when assessing their economics. Amyris is giving up a lot of value in the years ahead, but this makes sense when the cost of capital for Amyris and Givaudan is taken into account. Amyris will still ...

Summary Amyris is in dismal financial condition and will be required to raise additional capital to survive. This capital raise will likely be through equity, as the company would have a tough time getting affordable debt financing. Increasing losses and a terrible balance sheet are...

The U.S. Environmental Protection Agency said Wednesday it will propose a rule allowing sales of gasoline with a higher ethanol blend in some Midwest states, starting with the summer 2024 driving season. Some governors from corn-producing Midwestern states had asked the EPA to stop giving...